Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide is being studied as a triple hormone receptor agonist, targeting GLP-1, GIP, and glucagon
Important safety considerations : These medications are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
455-P: network meta-analysis of seven glucagon-like peptide-1 receptor agonists: a focus on cardiovascular outcomes trials data
Labarrere and Kassab, 2022), modulators of mannose binding lectin, C1q, C-reactive protein (Tang et al., 2011
How to Reconstitute Recommended solvent: Bacteriostatic (BAC) water the standard solvent for most peptides on this site
US$ 28.67
US$ 25.23
US$ 25.78
